I am pleased to share that our business activity has been exceptionally strong during the first nine months of 2021 as world economies reopen following the COVID lockdowns.
A low-interest-rate environment, coupled with equity markets at all-time highs this summer, contributed to growth in all our business units. While year-over-year inflation is up and concerns linger about how the spread of COVID variants may affect global economies, growth remains strong.
William Blair is also expanding. In July, we opened a Denver office to serve private wealth and banking clients in the region. It joins our growing roster of locations, including Singapore and The Hague, which were among our latest global expansions.
Looking forward, one of the business sectors that has seen huge advances with promises of more to come—from both an investment and health perspective—is the biotech industry. This issue of Client Focus takes a deep dive into the latest biotech discoveries.
As William Blair analysts Raju Prasad, Myles Minter, and Matt Larew describe in The Science of Possibilities, technology and medical breakthroughs in genomic medicines like the mRNA vaccines are ushering in a new era of healthcare.
The amazing discoveries young biotechs are uncovering—from next-gen vaccines and cures for heart disease and cancer—have caught the eyes of investors as well. John Sonnier, with the firm’s investment banking biopharma team, discusses the latest trends.
This issue also includes an informative Q&A on inflation with Olga Bitel, an economist and global strategist with our investment management team.
It has been an amazing nine months as we continue to see the world evolve amid effects of COVID. I am proud of and thankful for how the staff has responded. In addition to meeting clients’ needs, colleagues worked closely with our summer intern class of 2021—including Women in Technology and our community partner Greenwood Project—mentoring the next generation of financial leaders.
And, thank you for the trust you have placed in William Blair as your financial partner. We look forward to continuing to work with you and helping you meet your long-term goals.